Prostate Cancer

Prostate Biopsy Complication Rates Increasing

Prostate Biopsy Complication Rates Increasing

By

Urologic complications requiring hospital admission grew from 3.6% in 2000 to 3.9% in 2008, largely because of infections.

Radical Prostatectomy Outcomes Similar for Obese, Non-Obese

Radical Prostatectomy Outcomes Similar for Obese, Non-Obese

By

Outcomes of robot-assisted radical prostatectomy in obese patients are mostly comparable to non-obese patients.

Good Prostate Cancer (PCa) Outcomes Possible Despite Salvage Radiation Failure

Good Prostate Cancer (PCa) Outcomes Possible Despite Salvage Radiation Failure

By

Men who had PSA relapse after receiving post-radical surgery salvage radiation therapy had a median overall survival of nearly 14 years.

Early Adjuvant Radiotherapy Benefits Selected Prostate Cancer Patients

Early Adjuvant Radiotherapy Benefits Selected Prostate Cancer Patients

By

Radiotherapy given within 6 months of radical prostatectomy reduces cancer-specific mortality in men with highly aggressive disease.

Has the proportion of your patients undergoing prostate brachytherapy been declining?

Has the proportion of your patients undergoing prostate brachytherapy been declining?

By

Prostate cancer patients undergoing radical prostatectomy increased by double digits while those undergoing brachytherapy decreased.

Sexual Function Preserved in Prostate Cancer Combination Therapy

Sexual Function Preserved in Prostate Cancer Combination Therapy

High rates of preserved sexual function with combination beam plus brachytherapy.

Radical Prostatectomy Rates Rising

Radical Prostatectomy Rates Rising

By

Utilization rates jumped by double digits across prostate cancer risk groups from 2004 to 2011.

Male Pattern Baldness Linked with Prostate Cancer

Male Pattern Baldness Linked with Prostate Cancer

Men with male pattern baldness may face a higher risk of aggressive prostate cancer.

Statins Reduce Prostate Cancer Recurrence Risk After Radiotherapy

Statins Reduce Prostate Cancer Recurrence Risk After Radiotherapy

By

This benefit is not seen in patients who undergo radical prostatectomy, according to an updated meta-analysis.

Watchful Waiting Not Suitable for Black Men with Prostate Cancer

Watchful Waiting Not Suitable for Black Men with Prostate Cancer

Black prostate cancer patients more likely to develop aggressive disease earlier than white patients.

Aspirin Eases Genitourinary (GU) Toxicity from Prostate Cancer Radiotherapy

Aspirin Eases Genitourinary (GU) Toxicity from Prostate Cancer Radiotherapy

By

Low-dose aspirin decreased the likelihood of acute genitourinary toxicity in prostate cancer by 27%.

Genetic Variant May Predict Resistance to Prostate Cancer Drugs

Genetic Variant May Predict Resistance to Prostate Cancer Drugs

By

Enzalutamide and abiraterone may not benefit men with metastatic castration-resistant prostate cancer who have AR-V7 in circulating tumor cells.

Men with Metabolic Aberrations Have Lower Prostate Cancer Risk

Men with Metabolic Aberrations Have Lower Prostate Cancer Risk

By

However, they are more likely to die from causes other than prostate cancer than men with normal metabolic levels.

FDA Approves New Indication for Enzalutamide

FDA Approves New Indication for Enzalutamide

By

The drug is now also approved for use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

Brachytherapy Offers Favorable Long-Term Prostate Cancer Survival

Brachytherapy Offers Favorable Long-Term Prostate Cancer Survival

By

Study finds a 15-year cancer-specific survival rate of 94%; hormone therapy for more than 6 months decreases all-cause survival.

AR-V7 Cells Tied to Chemo Resistance in Prostate Cancer

AR-V7 Cells Tied to Chemo Resistance in Prostate Cancer

Detection of AR-V7 in circulating tumor cells linked to enzalutamide and abiraterone resistance.

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

By

New study highlights the importance of digital rectal examinations in PCa patients with normal-range PSA at diagnosis.

Poor Prostate Cancer Knowledge Associated with Decision Conflict

Poor Prostate Cancer Knowledge Associated with Decision Conflict

Findings seen in economically disadvantaged men with newly diagnosed prostate cancer.

Depression in Cancer Patients Often Untreated

Depression in Cancer Patients Often Untreated

Studies show integrated program effective for depression in patients with cancer.

Mental Illness Develops in 20% of Elderly Prostate Cancer Patients

Mental Illness Develops in 20% of Elderly Prostate Cancer Patients

By

Risk is greater in patients managed with watchful waiting than in those who undergo radical treatment.

Focal Prostate Cancer Therapy Safe, Feasible

Focal Prostate Cancer Therapy Safe, Feasible

By

In a study, none of the 62 men who had the treatment experienced erectile dysfunction or urinary incontinence.

MRI Highly Accurate in Detecting Significant Prostate Cancer

MRI Highly Accurate in Detecting Significant Prostate Cancer

By

Diffusion-weighted technique found to have a sensitivity and specificity of 89%-91% and 77%-81%, respectively.

Post-Brachytherapy Erectile Function Preserved in Most Men

Post-Brachytherapy Erectile Function Preserved in Most Men

By

At 5 years after seed implantation, 59% prostate cancer patients had preserved erectile function.

BRCA2 Mutation Ups Prostate Cancer Death Risk

BRCA2 Mutation Ups Prostate Cancer Death Risk

By

In a study, the 12-year prostate cancer survival rate was 61.8% for men with the mutation versus 94.3% for those without it.

Advanced Prostate Cancer Linked to Low Melatonin

Advanced Prostate Cancer Linked to Low Melatonin

By

Urinary levels of a melatonin metabolite below the median were associated with a 4-fold increased risk versus levels above the median.

Confirmed Drop in Prostate Cancer Deaths From PSA Screening

Confirmed Drop in Prostate Cancer Deaths From PSA Screening

Increased absolute effect at 13 years compared with findings at nine and 11 years.

Novel Urine Prostate Cancer Test Shows Promise

Novel Urine Prostate Cancer Test Shows Promise

By

It is more sensitive than digital rectal examination and transrectal ultrasound and more specific than PSA and PSA density, researchers report.

Neglected Side Effects of Radical Prostatectomy

Neglected Side Effects of Radical Prostatectomy

By

A questionnaire-based study revealed significant side effects that are not commonly discussed.

Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes

Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes

By

Reduced likelihood of biochemical recurrence of prostate cancer also linked to concomitant hormonal therapy and positive surgical margins.

Obesity Ups Bladder, Kidney Cancer Risk in Men

Obesity Ups Bladder, Kidney Cancer Risk in Men

By

As body mass index increases, so does the risk of kidney and bladder cancers in men and stomach, ovarian, and colon cancers in women.

Sign Up for Free e-newsletters